Jadlowiec CC, Taner T (2016) Liver transplantation: Current status and challenges. World J Gastroenterol 22(18):4438–4445. https://doi.org/10.3748/wjg.v22.i18.4438
Article PubMed PubMed Central CAS Google Scholar
Kim WR, Lake JR, Smith JM et al (2018) OPTN/SRTR 2016 annual data report: liver. Am J Transplant 18(Suppl 1):172–253. https://doi.org/10.1111/ajt.14559
Weber ML, Ibrahim HN, Lake JR (2012) Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl 18(11):1290–1301. https://doi.org/10.1002/lt.23522
Kalisvaart M, Schlegel A, Trivedi PJ et al (2019) Chronic kidney disease after liver transplantation: impact of extended criteria grafts. Liver Transpl 25(6):922–933. https://doi.org/10.1002/lt.25468
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 105(4S):S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
Ojo AO, Held PJ, Port FK et al (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349(10):931–940. https://doi.org/10.1056/NEJMoa021744
Article PubMed CAS Google Scholar
Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD (2014) Chronic kidney disease and associated mortality after liver transplantation–a time-dependent analysis using measured glomerular filtration rate. J Hepatol 61(2):286–292. https://doi.org/10.1016/j.jhep.2014.03.034
Article PubMed PubMed Central Google Scholar
Ramachandran J, Juneja R, John L et al (2010) Chronic kidney disease following liver transplantation: a South Australian experience. Transplant Proc 42(9):3644–3646. https://doi.org/10.1016/j.transproceed.2010.06.022
Article PubMed CAS Google Scholar
Cantarovich M, Tchervenkov J, Paraskevas S et al (2011) Early changesin kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation. Transplantation 92(12):1358–1363. https://doi.org/10.1097/TP.0b013e3182384aff
Lamattina JC, Foley DP, Mezrich JD et al (2011) Chronic kidney disease stage progression in liver transplant recipients. Clin J Am Soc Nephrol 6(8):1851–1857. https://doi.org/10.2215/CJN.00650111
Article PubMed PubMed Central Google Scholar
Gojowy D, Kubis P, Gorecka M, Karkoszka H, Wiecek A, Adamczak M (2020) Chronic kidney disease in patients after liver transplantation: a long-term retrospective analysis from 1 transplantation center. Transplant Proc 52(8):2492–2496. https://doi.org/10.1016/j.transproceed.2020.02.081
Article PubMed CAS Google Scholar
de Boccardo G, Kim JY, Schiano TD et al (2008) The burden of chronic kidney disease in long-term liver transplant recipients. Transplant Proc 40(5):1498–1503. https://doi.org/10.1016/j.transproceed.2008.03.099
Leithead JA, Ferguson JW, Hayes PC (2012) Modifiable patient factors are associated with the late decline in renal function following liver transplantation. Clin Transplant 26(3):E316–E323. https://doi.org/10.1111/j.1399-0012.2012.01650.x
Sato K, Kawagishi N, Fujimori K, Ohuchi N, Satomi S (2015) Renal function status in liver transplant patients in the first month post-transplant is associated with progressive chronic kidney disease. Hepatol Res 45:220
Wenger U, Neff TA, Oberkofler CE et al (2013) The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study. BMC Nephrol 14:37
PubMed PubMed Central Google Scholar
Jin H, Wei Y, Qian Y et al (2022) Renal histopathological lesions after liver transplantation: what can we find besides calcineurin inhibitor-induced nephrotoxicity? BMC Nephrol. 23(1):324. https://doi.org/10.1186/s12882-022-02952-y
Article PubMed PubMed Central CAS Google Scholar
Levey AS, Stevens LA, Schmid CH, et al (2009) A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155(6):408]. Ann Intern Med 150(9):604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO (2012) clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013(3):1–150
Modi RM, Patel N, Metwally SN, Mumtaz K (2016) Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol 8(24):999–1011. https://doi.org/10.4254/wjh.v8.i24.999.PMID:27648152;PMCID:PMC5002501
Article PubMed PubMed Central Google Scholar
Lee JP, Heo NJ, Joo KW et al (2010) Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function. Nephrol Dial Transpl 25(8):2772–2785. https://doi.org/10.1093/ndt/gfq093
Wong F, Leung W, Al Beshir M, Marquez M, Renner EL (2015) Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation. Liver Transpl 21(3):300–307. https://doi.org/10.1002/lt.24049
Dong V, Nadim MK, Karvellas CJ (2021) Post-liver transplant acute kidney injury. Liver Transpl 27(11):1653–1664. https://doi.org/10.1002/lt.26094
DellaVolpe J, Al-Khafaji A (2019) Acute kidney injury before and after liver transplant. J Intensive Care Med 34(9):687–695. https://doi.org/10.1177/0885066618790558
Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E (2009) Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Liver Transpl 15(12):1792–1797. https://doi.org/10.1002/lt.21920
Teperman L, Moonka D, Sebastian A et al (2013) Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl 19(7):675–689. https://doi.org/10.1002/lt.23658
Fischer L, Saliba F, Kaiser GM et al (2015) Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized. Multicenter Study Transplantation 99(7):1455–1462. https://doi.org/10.1097/TP.0000000000000555
Article PubMed CAS Google Scholar
Zhang W, Fung J (2017) Limitations of current liver transplant immunosuppressive regimens: renal considerations. Hepatobiliary Pancreat Dis Int 16(1):27–32. https://doi.org/10.1016/s1499-3872(16)60167-4
Article PubMed CAS Google Scholar
Sterneck M, Kaiser GM, Heyne N et al (2014) Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation. Am J Transplant 14(3):701–710. https://doi.org/10.1111/ajt.12615
Article PubMed PubMed Central CAS Google Scholar
Foerster F, Hoppe-Lotichius M, Vollmar J et al (2019) Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre. United European Gastroenterol J 7(6):838–849. https://doi.org/10.1177/2050640619840221
Article PubMed PubMed Central Google Scholar
Filgueira NA (2019) Hepatocellular carcinoma recurrence after liver transplantation: risk factors, screening and clinical presentation. World J Hepatol 11(3):261–272. https://doi.org/10.4254/wjh.v11.i3.261
Article PubMed PubMed Central Google Scholar
USRDS 2020 Annual Report 2020. https://adr.usrds.org/2020/end-stage-renal-disease/11-international-comparisons.
Wu MY, Wu MS (2018) Taiwan renal care system: a learning health-care system [published correction appears in Nephrology (Carlton). 2019 May;24(5):586]. Nephrology (Carlton) 23 Suppl 4:112–115. https://doi.org/10.1111/nep.13460
Guitard J, Ribes D, Kamar N et al (2006) Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail 28(5):419–425. https://doi.org/10.1080/08860220600683607
Comments (0)